Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Bundred

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Breast Cancer Research and Treatment|November 2, 2022
Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind AllianceShelley Potter, Katherine Fairhurst, Katherine Cowan, et al.
British Journal of Cancer|December 16, 2021
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancerMichelle Harvie, Mary Pegington, Sacha J Howell, et al.
Journal of the National Cancer Institute|May 4, 2006
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC TrialRobert E Mansel, Lesley Fallowfield, Mark Kissin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred, Nuria Porta, Adrian Murray Brunt, et al.
Nature Communications|November 10, 2016
Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivationPascal Gellert, Corrinne V Segal, Qiong Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast CancerPeter Schmid, Sarah E Pinder, Duncan Wheatley, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Breast Cancer Research and Treatment|November 2, 2022
Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind AllianceShelley Potter, Katherine Fairhurst, Katherine Cowan, et al.
British Journal of Cancer|December 16, 2021
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancerMichelle Harvie, Mary Pegington, Sacha J Howell, et al.
Journal of the National Cancer Institute|May 4, 2006
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC TrialRobert E Mansel, Lesley Fallowfield, Mark Kissin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred, Nuria Porta, Adrian Murray Brunt, et al.
Nature Communications|November 10, 2016
Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivationPascal Gellert, Corrinne V Segal, Qiong Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast CancerPeter Schmid, Sarah E Pinder, Duncan Wheatley, et al.
Pageof 4